Valuation: QuidelOrtho Corporation

Market Cap 966M 862M 795M 722M 1.36B 91.46B 1.38B 9.58B 3.77B 47.92B 3.62B 3.55B 152B P/E 2026 *
-3.42x
P/E 2027 * -5.05x
Enterprise Value 3.68B 3.28B 3.03B 2.75B 5.16B 348B 5.24B 36.48B 14.37B 183B 13.8B 13.51B 578B EV / Sales 2026 *
1.45x
EV / Sales 2027 * 1.39x
Free-Float
99.08%
Yield 2026 *
-
Yield 2027 * -
1 day-4.26%
1 week-3.09%
Current month+27.89%
1 month+23.22%
3 months-19.18%
6 months+13.28%
Current year-52.80%
1 week 12.68
Extreme 12.685
14.65
1 month 9.93
Extreme 9.93
14.65
Current year 9.92
Extreme 9.92
35.58
1 year 9.92
Extreme 9.92
35.58
3 years 9.92
Extreme 9.92
75.86
5 years 9.92
Extreme 9.92
180.06
10 years 9.92
Extreme 9.92
306.72
Manager TitleAgeSince
Chief Executive Officer 61 05/05/2024
Director of Finance/CFO 48 05/07/2026
Chief Operating Officer 57 14/11/2024
Director TitleAgeSince
Chairman 72 10/12/2022
Director/Board Member 71 31/12/2021
Director/Board Member 82 31/12/1992
Date Insider Type Main position Quantity % Market Cap. Importance
15/09/26 Exercice

Head of Human Resources

6,053 0.0088%
15/08/26 Exercice

EVP Global Port. Mgmt & Mkting

1,054 0.0015% -
15/07/26 Free

Chief Financial Officer

356,555 0.5251%
Change 5-day change 1-year change 3-year change Capi.($)
-4.26%-3.09%-54.77%-79.86% 966M
-2.52%-2.86%+19.28%+46.50% 257B
-1.76%-0.76%+5.34%+12.59% 164B
+3.67%+3.74%-15.78%+62.83% 151B
+3.37%+4.24%-55.70%-8.22% 64.51B
+0.12%+4.22%-14.07%-9.22% 52.1B
+0.62%+3.04%+11.25%+65.30% 51.9B
+1.91%+2.26%+17.24%+30.47% 50.95B
-2.17%-0.95%+19.21%+59.04% 50.11B
-0.41%+2.58%+30.67%+78.20% 44.95B
Average -0.48%+3.41%-3.73%+25.76% 88.77B
Weighted average by Cap. -0.55%+3.50%+3.22%+38.11%

Financials

2026 *2027 *
Net sales 2.54B 2.27B 2.09B 1.9B 3.57B 241B 3.63B 25.24B 9.94B 126B 9.55B 9.34B 400B 2.59B 2.31B 2.13B 1.94B 3.64B 245B 3.69B 25.7B 10.12B 129B 9.73B 9.52B 407B
Net income -282M -251M -232M -211M -395M -26.68B -401M -2.79B -1.1B -13.98B -1.06B -1.03B -44.28B -191M -171M -158M -143M -268M -18.12B -273M -1.9B -748M -9.49B -718M -703M -30.07B
Net Debt 2.71B 2.42B 2.23B 2.03B 3.81B 257B 3.86B 26.9B 10.6B 135B 10.18B 9.96B 426B 2.63B 2.34B 2.16B 1.96B 3.68B 249B 3.74B 26.05B 10.26B 130B 9.85B 9.64B 413B
Projected Income Statement - Annual - QuidelOrtho Corporation
Logo QuidelOrtho Corporation
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.
Employees
6,500
Date Price Change Volume
22/10/26 US$13.48 -4.26% 1,643,064
21/10/26 US$14.08 -0.91% 3,317,471
20/10/26 US$14.21 +11.36% 2,643,829
19/10/26 US$12.76 -1.16% 1,425,143
16/10/26 US$12.91 -7.19% 1,788,435
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - QuidelOrtho Corporation
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
14.08USD
Average target price
14.67USD
Spread / Average Target
+4.17%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - QuidelOrtho Corporation
  1. Stock Market
  2. Stocks
  3. QDEL Stock